AI assistant
Sending…
PTC THERAPEUTICS, INC. — Director's Dealing 2014
Dec 2, 2014
31046_dirs_2014-12-01_bbd8f489-da2a-4f1e-8b36-1aca6a6f3045.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-12-01
Reporting Person: Hirawat Claudia de Oliveira Ribeiro (President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-01 | Common Stock | M | 417 | $10.85 | Acquired | 39194 | Direct |
| 2014-12-01 | Common Stock | S | 300 | $43.68 | Disposed | 38894 | Direct |
| 2014-12-01 | Common Stock | S | 117 | $44.78 | Disposed | 38777 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-01 | Stock Option (right to buy) | $10.85 | M | 417 | Disposed | 2023-05-15 | Common Stock (417) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 194 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
F2: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
More from PTC THERAPEUTICS, INC.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20